# Beijing Zhuokai Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-zhuokai-biotechnology-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.joekai.com
- Total disclosed funding: $7.8M
- Latest round: Series B (Apr 13, 2022)
- Investors on record: 5

## About

Based in Beijing, China, and founded in 2001 by Zhong Yi, Beijing Zhuokai Biotechnology Co., Ltd., a.k.a. Zhuokai Biotech operates as a biotech company that develops drugs for the treatment of neurogenetic disorders, such as Alzheimer's disease, Autism, Parkinson's disease, and Schizophrenia, and more. In April 2022, JoeKai Biotech raised a Series B+ funding from new investor Legend Capital.

The company has developed a drosophila model of Alzheimer's disease and the drosophila olfactory memory screening platform in China. and other CNS Drosophila models. The platform provided research and development outsourcing (CRO) services to multiple companies and scientific research institutions. Based on the drosophila screening platform, Zhuokai Biotech has established a mouse pharmacodynamics verification platform, which fully confirmed the transformability of the platform. By leveraging the above platform, the firm has a clinical phase I pipeline 50561 for the treatment of Alzheimer's disease, two pipelines that are about to enter the clinical phase, and 2 early-stage programs.

The company's products include class 1.1 drug 50561 for the treatment of Alzheimer's disease, a commonly used pediatric drug to improve autism's stereotyped behavior, compound Agiforget, and class 1.1 small molecule JK-new to prevent neuronal death in gradual freezing syndrome.

## Funding rounds

- Series B, Apr 13, 2022 — Legend Capital
- Series B, Oct 15, 2021 — Dynamic Capital
- Series B, Jun 16, 2021, $7.8M — MSA Capital, Lotus Lake Capital, Tao Capital

## Investors

- MSA Capital (https://capitalatlas.ai/funds/msa-capital) — Series B
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series B
- Tao Capital (https://capitalatlas.ai/funds/tao-capital) — Series B
- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Series B
- Legend Capital — Series B